SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACOR

NEW YORK, Dec. 16, 2017 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ: ACOR) and certain of its officers.   The class action, filed in United States District Court, for the…